News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Critical Therapeutics, Inc. (CRTX) Files Registration Statement on Form S-4 with Securities and Exchange Commission


7/22/2008 9:13:41 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that it has filed a Registration Statement on Form S-4 with the Securities and Exchange Commission containing the preliminary Proxy Statement/Prospectus in connection with the previously announced merger agreement between Critical Therapeutics and Cornerstone BioPharma Holdings, Inc. (Cornerstone). Cornerstone is a privately-held specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES